Retrospective cohort study of concomitant use of direct anti‐coagulants like rivaroxaban, apixaban or dabigatran with macrolides/fluoroquinolones
Latest Information Update: 09 Dec 2020
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Macrolides (Primary) ; Rivaroxaban (Primary) ; Tetracyclines (Primary)
- Indications Atrial fibrillation; Deep vein thrombosis; Pulmonary embolism
- Focus Adverse reactions; Pharmacodynamics
- 09 Dec 2020 New trial record